#VisualAbstract: Oral Glucose-Lowering Agents are Not Noninferior to Insulin for Gestational Diabetes
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: insulin
Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes
1. Once weekly efsitora demonstrated non-inferiority compared with degludec with regards to change in HbA1c. 2. Patients in the efsitora ...
#VisualAbstract: Insulin Efsitora is Noninferior to Degludec in Type 2 Diabetes without Previous Insulin Treatment
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
Novo Nordisk: Awiqli is a once-weekly insulin injection for patients with type 2 diabetes
Awiqli led to greater glycated hemoglobin (HbA1c) reduction, superior blood sugar reduction, and time spent within the recommended blood sugar ...
Voice-based conversational artificial intelligence may improve insulin management for diabetes
1. This randomized clinical trial demonstrated that compared with the standard of care, voice-based conversational artificial intelligence (VBAI) improved time ...
Once-weekly insulin icodec non-inferior to daily insulin degludec in patients with type 1 diabetes
1. Mean HbA1c reduction at 26 weeks was comparable in the weekly icodec and daily degludec groups. 2. The risk ...
#VisualAbstract: Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes
Click to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Retatrutide associated with improved glycemic control and bodyweight reduction in type 2 diabetes
1. HbA1c and bodyweight reduction were greater in the retatrutide group compared to dulaglutide and placebo. 2. The effect of ...
#VisualAbstract:Insulin icodec is more effective than insulin glargine for glycemic control
In this randomized controlled trial, weekly insulin icodec use resulted in better glycemic control than daily insulin glargine in patients with ...